Superbug drugs firm backs takeover by Novartis

A biotech firm involved in developing drugs for fighting hospital superbugs today backed a £305m (€444m) takeover by pharmaceuticals giant Novartis.

Superbug drugs firm backs takeover by Novartis

A biotech firm involved in developing drugs for fighting hospital superbugs today backed a £305m (€444m) takeover by pharmaceuticals giant Novartis.

The proposed deal for NeuTec Pharma will earn windfalls for the couple who set up the business at the University of Manchester less than 10 years ago.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited